{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:21:00Z","timestamp":1788283260102,"version":"build-2803163510"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Congenital afibrinogenemia is a rare disorder characterized by a lack of detectable fibrinogen. The mainstay of treatment for acute bleeding episodes or perioperative management is replacement with fibrinogen concentrate or fibrinogen-containing blood products. The development of neutralizing antibodies and severe allergic reactions to fibrinogen replacement is rarely reported in afibrinogenemia patients. Here the treatment regimen is described for a 6-year-old girl with a severe allergic reaction to multiple fibrinogen-containing products who became refractory to treatment because of a presumed inhibitor to fibrinogen.<\/jats:p>","DOI":"10.1097\/mph.0000000000001812","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T23:30:13Z","timestamp":1588030213000},"page":"e260-e263","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Blood, Sweat, and Fears: A Novel Mutation Associated With Anaphylaxis and Nonresponse in a Patient With Afibrinogenemia"],"prefix":"10.1097","volume":"43","author":[{"given":"Emily","family":"Hsieh","sequence":"first","affiliation":[{"name":"Baylor College of Medicine"},{"name":"Texas Children\u2019s Cancer and Hematology Centers"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Conneely","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"},{"name":"Texas Children\u2019s Cancer and Hematology Centers"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Teruya","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"},{"name":"Texas Children\u2019s Cancer and Hematology Centers"},{"name":"Division of Transfusion Medicine & Coagulation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Nicholas","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"},{"name":"Section of Allergy & Immunology, Texas Children\u2019s Hospital, Feigin Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Miller","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"},{"name":"Section of Allergy & Immunology, Texas Children\u2019s Hospital, Feigin Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YoungNa","family":"Lee-Kim","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"},{"name":"Texas Children\u2019s Cancer and Hematology Centers"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"R1-20260901","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0049-3848(13)70004-5","article-title":"Epidemiology and treatment of congenital fibrinogen deficiency","volume":"130","author":"Peyvandi","year":"2012","journal-title":"Thromb Res"},{"key":"R2-20260901","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0002-9343(61)90057-2","article-title":"Precipitating antifibrinogen antibody appearing after fibrinogen infusions in a patient with congenital afibrinogenemia","volume":"30","author":"de Vries","year":"1961","journal-title":"Am J Med"},{"key":"R3-20260901","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/01.STR.30.11.2479","article-title":"Recurrent spontaneous intracerebral hemorrhage in a congenitally afibrinogenemic patient: diagnostic pitfalls and therapeutic options","volume":"30","author":"Henselmans","year":"1999","journal-title":"Stroke"},{"key":"R4-20260901","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1365-2516.2006.01340.x","article-title":"Management of acute bleeding in a patient with congenital afibrinogenaemia","volume":"12","author":"Vakalopoulou","year":"2006","journal-title":"Haemophilia"},{"key":"R7-20260901","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/jth.13923","article-title":"Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency","volume":"16","author":"Ross","year":"2018","journal-title":"J Thromb Haemost"},{"key":"R8-20260901","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1160\/TH14-06-0514","article-title":"Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data","volume":"113","author":"Solomon","year":"2015","journal-title":"Thromb Haemost"},{"key":"R9-20260901","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1538-7836.2011.04424.x","article-title":"Fibrinogen replacement therapy for congenital fibrinogen deficiency: congenital fibrinogen deficiency","volume":"9","author":"Bornikova","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R10-20260901","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/hae.12730","article-title":"US guidelines for immune tolerance induction in patients with haemophilia a and inhibitors","volume":"21","author":"Valentino","year":"2015","journal-title":"Haemophilia"},{"key":"R11-20260901","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/bcp.14147","article-title":"Population pharmacokinetics of a triple-secured fibrinogen concentrate administered to afibrinogenaemic patients: observed age\u2010 and body weight-related differences and consequences for dose adjustment in children","volume":"86","author":"Bellon","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"R12-20260901","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/hae.13876","article-title":"Fibrinogen concentrates in hereditary fibrinogen disorders: past, present and future","volume":"26","author":"Casini","year":"2020","journal-title":"Haemophilia"},{"key":"R13-20260901","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1538-7836.2009.03633.x","article-title":"Pharmacokinetics and safety of fibrinogen concentrate","volume":"7","author":"Manco-Johnson","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R14-20260901","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1365-2516.2008.01831.x","article-title":"Rare inherited disorders of fibrinogen","volume":"14","author":"Acharya","year":"2008","journal-title":"Haemophilia"},{"key":"R15-20260901","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1365-2516.2009.02039.x","article-title":"Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006)","volume":"15","author":"Chitlur","year":"2009","journal-title":"Haemophilia"},{"key":"R16-20260901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.12860","article-title":"Achievements, challenges and unmet needs for haemophilia patients with inhibitors: report from a symposium in Paris, France on 20 November 2014","volume":"22","author":"Dargaud","year":"2016","journal-title":"Haemophilia"},{"key":"R17-20260901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19061597","article-title":"Human fibrinogen: molecular and genetic aspects of congenital disorders","volume":"19","author":"Tiscia","year":"2018","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000001812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:03:52Z","timestamp":1788282232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000001812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001812","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"assertion":[{"value":"2019-09-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}